The Canadian Securities Exchange (CSE) confirmed its position on the listing of cannabis firms with assets or operations in the USA.
"Currently, there are conflicting U.S. federal and state laws concerning the legality of medical and recreational cannabis," it said in a brief statement.
"The CSE maintains that companies with exposure to the U.S. cannabis industry need to provide a complete risk disclosure for investors. This should include a comprehensive discussion of the current legal framework. All CSE-listed companies are required to comply.
It added that exchange would continue to accept applications from companies that meet listing requirements and provide appropriate disclosure.
"The CSE is "The Exchange For Entrepreneurs”, and we are pleased to be receiving growing interest from entrepreneurs in the U.S. cannabis space, where a rapidly evolving legal framework has created significant investment opportunities,” said Richard Carleton, chief executive.
“Provided that these companies offer appropriate risk disclosure and demonstrate that they are operating in accordance with applicable laws, we believe that they are valuable additions to our well-regulated exchange.”